You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CTMX Sale Disclosure
Mccarthy Sean A. · SEC Form 4 · Filed Oct 16, 2026
Sale
Calculated transaction value
$461.91K
Mccarthy Sean A. CEO
CTMX
CytomX Therapeutics
CTMX
Transaction date
Nov 6, 2025
Public filing date
Oct 16, 2026
Filing lag
Filed 344 days later
CTMX daily price context
Close on/before transaction
$4.19
Nov 6, 2025
First close after public filing
$2.34
Oct 19, 2026
Return after filing · so far
-11.97%
Through Nov 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 101,793 shares @ $4.54
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4/A
- Filing identifier
- 0001610717-26-000442
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$623.76K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cytomx Therapeutics, Inc. CTMX Current | Sale | Nov 6, 2025 | $461.91K |
| Cytomx Therapeutics, Inc. CTMX | Exercise | Nov 6, 2025 | $161.85K |
| Cytomx Therapeutics, Inc. CTMX | Exercise | Nov 6, 2025 | $0 |